Ascendis Pharma A (ASND) Revenue Growth (1y) (2015 - 2026)
Ascendis Pharma A (ASND) Revenue Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 64.30% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn | 171.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 171.87% |
| Dec 31, 2025 | 46.35% |
| Sep 30, 2025 | 293.22% |
| Jun 30, 2025 | 361.49% |
| Mar 31, 2025 | 1.94% |
| Dec 31, 2024 | 1.70% |
| Sep 30, 2024 | 21.47% |
| Jun 30, 2024 | -24.88% |
| Mar 31, 2024 | 188.96% |
| Dec 31, 2023 | 1,294.35% |
| Sep 30, 2023 | 239.18% |
| Jun 30, 2023 | 685.13% |
| Mar 31, 2023 | 370.45% |
| Dec 31, 2022 | -76.29% |
| Sep 30, 2022 | 1,074.55% |
| Jun 30, 2022 | 434.06% |
| Mar 31, 2022 | 751.62% |
| Dec 31, 2021 | 19.57% |
| Sep 30, 2021 | -59.24% |
| Jun 30, 2021 | -22.19% |